On 17 April, the 7-day rolling average of daily new confirmed cases of COVID-19 moved above its January 2021 high, to 766,231 cases. SGX listed medical supplier stocks - Top Glove, Medtecs International, Riverstone, UG Healthcare and Aspen Group have all gained in the April month to 16 April, averaging 11.7% gains over the 11 sessions.
Effective 13 April 2021, Frasers Logistics & Commercial Trust has joined the STI with an indicative weight of 1.3%, taking the number of REITs within the STI to 7, with a combined Index weight of ~15%. This makes REITs the 3rd largest Sector by Index weight of the STI after Financials and Industrials.
Singapore’s 21 most traded non-STI stocks in the 2021 year-to-date have traded S$220 million in turnover a day, 15% of the total turnover of all stocks and trusts listed on SGX. Thomson Medical, iFAST & ISDN led the 21 stocks in the year-to-date.
For 1Q21, there were 37 SGX primary-listed stocks that conducted buybacks over the quarter, with consideration totaling S$134 million. Over the quarter, the Straits Times Index (STI) gained 11.3%, and the buyback consideration represented 0.01 per cent of the S$943.8 billion in market capitalisation of all stocks listed on SGX as of 31 March.
With 3 sessions remaining for the March 2021, the STI has generated an 11.1% price gain year-to-date, outpacing all the major world benchmarks. The 1Q21 quarter is also poised to be the STI’s best start to a calendar year since 2012. As many as 11 of the STI stocks - Jardine Strategic, Yangzijiang Shipbuilding, Singapore Airlines, Hongkong Land, Jardine Matheson, CapitaLand, OCBC, Wilmar International, Jardine Cycle & Carriage, DBS and UOB have generated double digit gains in the quarter-to-date.
Singapore’s 10 most traded technology stocks keeping pace with the global trend, averaging a 50% total return since end 2019. The 10 stocks which include AEM, Venture Corporation, UMS, ISDN, Frencken Group, Fu Yu Corporation, CSE Global and Valuetronics have averaged 15% gains in the 2021 year-to-date.
Retail investors have been net sellers of STI stocks in the year-to-date, with Yangzijiang Shipbuilding, SATS, DBS Group, OCBC Bank and Singapore Airlines recipient to the highest net retail outflows proportionate to current market capitalisation. Combined turnover of the 2 STI ETFs is up 88% y-o-y.
The technology unit of Aztech Group (previously listed on SGX) – Aztech Global (SGX:8AZ) provides one-stop design and manufacturing services. With core strengths in R&D, design, engineering and manufacturing, its key products include IoT Devices, Data-communication and LED lighting.
The STI Reserve List are Frasers Logistics & Commercial Trust, Keppel REIT, Suntec REIT, Frasers Centrepoint Trust and NetLink NBN Trust. Should the Jardine Strategic amalgamation resolution be approved at the EGM, the STI Reserve stock with the highest market cap at the close two days prior to the Index deletion of Jardine Strategic will join the STI.
Singapore’s 5 most traded technology stocks – AEM, Venture Corp, UMS, ISDN and Nanofilm Technologies have averaged 16% gains in the 2020 year-to-date, bringing their 12-month average total return to 87%.
These articles are provided by SGX My Gateway.
SGX's investor education portal with market, product and investment information and events. Sign up now at sgx.com/mygateway to receive our investment updates and economic calendar.
These articles are not intended for distribution to, or for use by or to be acted on by any person or entity located in any jurisdiction where such distribution, use or action would be contrary to applicable laws or regulations or would subject Singapore Exchange Limited (“SGX”) to any registration or licensing requirement. This document is not an offer or solicitation to buy or sell, nor financial advice or recommendation for any investment product. This document is for general circulation only. It does not address the specific investment objectives, financial situation or particular needs of any person. Advice should be sought from a financial adviser regarding the suitability of any investment product before investing or adopting any investment strategies. Use of and/or reliance on this document is entirely at the reader’s own risk. Further information on this investment product may be obtained from www.sgx.com. Investment products are subject to significant investment risks, including the possible loss of the principal amount invested. Past performance of investment products is not indicative of their future performance. Examples provided are for illustrative purposes only. While each of SGX and its affiliates (collectively, the “SGX Group Companies”) have taken reasonable care to ensure the accuracy and completeness of the information provided, each of the SGX Group Companies disclaims any and all guarantees, representations and warranties, expressed or implied, in relation to this document and shall not be responsible or liable (whether under contract, tort (including negligence) or otherwise) for any loss or damage of any kind (whether direct, indirect or consequential losses or other economic loss of any kind, including without limitation loss of profit, loss of reputation and loss of opportunity) suffered or incurred by any person due to any omission, error, inaccuracy, incompleteness, or otherwise, any reliance on such information, or arising from and/or in connection with this document. The information in this document may have been obtained via third party sources and which have not been independently verified by any SGX Group Company. No SGX Group Company endorses or shall be liable for the content of information provided by third parties. The SGX Group Companies may deal in investment products in the usual course of their business, and may be on the opposite side of any trades. SGX is an exempt financial adviser under the Financial Advisers Act (Cap. 110) of Singapore. The information in this document is subject to change without notice. This document shall not be reproduced, republished, uploaded, linked, posted, transmitted, adapted, copied, translated, modified, edited or otherwise displayed or distributed in any manner without SGX’s prior written consent.